Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Eight infants (6 female, 2 male) with salt-losing congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency were studied to determine the sodium deficit at diagnosis and the level of salt supplement required in addition to subsequent hormone replacement. The median sodium deficit at diagnosis was 34 mmol (range 16-78) or 10.5 mmol/kg (range 4-24). A mean sodium supplement of 2.2 mmol/kg per day (range 0.5-4.9), double the amount provided with feeds, was required to maintain plasma sodium concentration and plasma renin activity (PRA) in the normal range for age. We present an equation based on sodium output (urine), sodium input (feeding plus supplement) and plasma sodium concentration to calculate the sodium supplement needed to maintain sodium balance on hormone replacement in this condition and some practical management suggestions. The necessity for salt supplements is often underestimated and the salt-losing tendency exacerbated by infection remains an unnecessary reason for hospitalization during the first months of life. In patients with salt-losing CAH life-long mineralocorticoid treatment is necessary but additional salt supplements are needed to maintain plasma sodium concentration and PRA in the normal range during infancy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in patients with salt-wasting CAH, this amount is insufficient, and sodium chloride supplements are recommended (182).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [182]
Citations
Cites
MENARD, J. *., & CATT, K. J. (1972) · Endocrinology · doi:10.1210/endo-90-2-422 · Cited by 454 · cited 1×
“PRA (pmol ml 1 h-Z) was measured by a radio-immunoassay of angiotensin I as described by Menhard and Catt [18].”
MethodDarrow, D. C., & Yannet, H. (1935) · Journal of Clinical Investigation · doi:10.1172/jci100674 · Cited by 271 · cited 1×
“is the TBW [9] and the plasma sodium concentration is determined by the total body sodium content and the TBW [3, 9, 15].”
BackgroundCOMPOSITION OF HUMAN COLOSTRUM AND MILK
MACY, I. G. (1949) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1949.02030050604009 · Cited by 194 · cited 1×
“In addition, the normal environment encountered by the infant is one in which availability of dietary sodium is limited, since breast and formula milk have a low sodium content of approximately 8 and 8-12mmol/1 respectively [16].”
BackgroundMolecular and clinical advances in congenital adrenal hyperplasia
Miller, W. L., & Levine, L. S. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80334-7 · Cited by 178 · cited 2×
“21-Hydroxylase deficiency may present as the classical salt-losing or simple virilizing type of congenital adrenal hyperplasia (CAH) and in a variety of mild non-classical forms [19].”
BackgroundKominami, S., Ochi, H., Kobayashi, Y., & Takemori, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85711-3 · Cited by 171
RÖSLER, A., LEVINE, L. S., SCHNEIDER, B., NOVOGRODER, M., & NEW, M. I. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-3-500 · Cited by 122
Matteson, K. J., Phillips, J. A., Miller, W. L., Chung, B. C., Orlando, P. J., Frisch, H., Ferrandez, A., & Burr, I. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5858 · Cited by 104 · cited 1×
“DNA studies have shown that gene deletions are not a common cause of the salt-losing variety and indicate that the salt-losing phenotype is due to many different lesions resulting in inactivation of the P-450c21B gene [ 17 ].”
BackgroundPlasma renin activity and aldosterone concentration in the human newborn.
Dillon, M. J., Gillin, M. E., Ryness, J. M., & de Swiet, M. (1976) · Archives of Disease in Childhood · doi:10.1136/adc.51.7.537 · Cited by 104 · cited 2×
“As our data show clearly, PRA tends to normal values for age [4] on addi-”
BackgroundManagement of congenital adrenal hyperplasia.
Hughes, I. A. (1988) · Archives of Disease in Childhood · doi:10.1136/adc.63.11.1399 · Cited by 61 · cited 1×
“The treatment of 21-hydroxylase deficiency is wellestablished and consists primarily of replacement of the deficient steroid hormones [11, 25].”
BackgroundHORNER, J. M., HINTZ, R. L., & LUETSCHER, J. A. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-5-776 · Cited by 50
Monitoring treatment in congenital adrenal hyperplasia.
Appan, S., Hindmarsh, P. C., & Brook, C. G. (1989) · Archives of Disease in Childhood · doi:10.1136/adc.64.9.1235 · Cited by 49
Self-citationMOREL, Y., DAVID, M., FOREST, M. G., BETUEL, H., HAUPTMAN, G., ANDRE, J., BERTRAND, J., & MILLER, W. L. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-3-592 · Cited by 43 · cited 1×
“Different manifestations of CAH, severe saltlosing, mild salt-losing and non-classical forms, have been described in the same family [20].”
BackgroundThe Physiological Basis of Medical Practice
&NA; (1946) · Academic Medicine · doi:10.1097/00001888-194603000-00019 · Cited by 43
Systolic blood pressure measurement in the newborn infant with the transcutaneous doppler method
Kirkland, R. T., & Kirkland, J. L. (1972) · The Journal of Pediatrics · doi:10.1016/s0022-3476(72)80452-9 · Cited by 38
Major mineral elements in dairy products
Feeley, R. M., Criner, P. E., Murphy, E. W., & Toepfer, E. W. (1972) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)15318-0 · Cited by 36 · cited 1×
“cows' milk) [6] are taken but the impor tance of maintaining”
BackgroundMarginal comment: Current approaches to the treatment of congenital adrenal hyperplasia
Winter, J. S. D. (1980) · The Journal of Pediatrics · doi:10.1016/s0022-3476(80)80135-1 · Cited by 34
Dyas, J., Read, G. F., Guha-Maulik, T., Hughes, I. A., & Riad-Fahmy, D. (1984) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456328402100514 · Cited by 34 · cited 1×
“Plasma 17OH-progesterone levels were measured using a magnetisable solid-phase antiserum [5] and 24 h urine steroid profile assessed by gas-liquid-chromatography.”
MethodCongenital adrenal hyperplasia: Renin and steroid values during treatment
Grant, D., Dillon, M. J., Atherden, S. M., & Levinsky, R. J. (1977) · European Journal of Pediatrics · doi:10.1007/bf00443127 · Cited by 31 · cited 2×
“Patients with 21-hydroxylase deficiency have been divided into those who are overt salt-losers and those who are simply virilized, but a majority of patients in infancy have a tendency for salt-wasting which varies in severity [7] depending on the impairment of aldosterone synthesis.”
BackgroundMETABOLISM OF CALCIUM, STRONTIUM, AND OTHER MINERALS IN THE PERINATAL PERIOD
Widdowson, E., McCance, R. A., Harrison, G. E., & Sutton, A. (1962) · The Lancet · doi:10.1016/s0140-6736(62)90229-5 · Cited by 17 · cited 1×
“The parameters relevant to salt loss before hormone replacement are shown in Table 1. At this stage, median weight-loss was 13.5% of birth-weight (range 8-15), which was assumed to be fluid; hyponatraemic hyperkalaemia was characteristic; the sodium loss in urine was 3-4 times that expected in normal neonates [2], whe…”
BackgroundInfluentialGUEUX, B., Fiet, J., Galons, H., Boneté, R., Villette, J., Vexiau, P., Pham-Huu-Trung, M.-T., Raux-Demay, M. C., Gourmelen, M., Brérault, J.-L., et al. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90043-4 · Cited by 11 · cited 1×
“In addition, studies showing increased plasma 21deoxycorticosterone levels in patients with CAH suggest that a variable defect of the mineralocorticoid pathway is a common feature [8].”
BackgroundNATRIURETIC ACTIVITY OF 16α-HYDROXYPROGESTERONE IN MAN
Jacobs, D. R. (1969) · European Journal of Endocrinology · doi:10.1530/acta.0.0610275 · Cited by 9
Manual of Pediatric Therapeutics
Bruton, O. C. (1975) · Military Medicine · doi:10.1093/milmed/140.6.419 · Cited by 9
Chaptal, J., Jean, R. A., Guillaumot, R., & MOREL, G. (1963) · PubMed · Cited by 3
Body water, sodium, potassium and hydrogen ions: Some basic facts and concepts
MORGAN, D. B. (1984) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(84)80020-1 · Cited by 1 · cited 1×
“7 introduced on the basis that TBW comprises 70% of body weight in neonates and infants [9, 15, 21].”
Background
Research works printed but not linked: 2
- Chaptal J, Jean R, Guillaumot R, Morel G (1963) Etude statistique de l'elimination urnaire des electrolytes chez l'enfant normal a differents ages. Arch Fr Pediatr 20:905–931
- Prader A (1954) Der Genitalbefund beim Pseudohermaphroditismus femininus des kongenitalen adrenogenitalen Syndroms. Morphologie, Häufigkeit, Entwicklung und Vererbung der verschiedenen Genitalformen. Helv Paediatr Acta 9:231–243
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
PW, S., W, A., RJ, A., LS, B., GS, C., DP, M., HFL, M.-B., WL, M., MH, M., SE, O., et al. (2019) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.16.8.5 · Cited by 300
Metadata
- Authors
- Mullis, P. E., Hindmarsh, P. C., & Brook, C. G. D.
- ORCID
- Hindmarsh, P. C.
- Venue
- European Journal of Pediatrics
- Published
- 1990-11
- Volume
- 150
- Issue
- 1
- Pages
- 22-25
- ISSN
- 0340-6199 (ISSN-L)
- 1432-1076
- OpenAlex
- W1997000704
- Cited by
- 53
- References
- 25
- Citations by year
- 2026: 1 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 5 · 2017: 2 · 2016: 1 · 2015: 3 · 2013: 2 · 2012: 1
- FWCI
- 0.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Keywords
- salt-losing congenital adrenal hyperplasia, 21-hydroxylase deficiency, sodium chloride supplementation, sodium deficiency, plasma sodium, plasma renin activity, mineralocorticoid replacement therapy, sodium balance, infancy
- MeSH terms
- Adrenal Hyperplasia, Congenital, Female, Fludrocortisone, Humans, Hydrocortisone, Infant, Newborn, Male, Sodium Chloride, Sodium, Dietary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.